Storia della carriera di Todd James
Precedenti posizioni note di Todd James
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/01/2022 | 01/10/2023 |
| Corporate Officer/Principal | 01/01/2022 | 01/10/2023 | |
| ACCELERON PHARMA INC. | Contatto Relazioni con gli Investitori | 01/01/2015 | 01/12/2021 |
| Public Communications Contact | 01/01/2015 | 01/12/2021 | |
Trout Capital LLC
 Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Stratega di mercato | 01/09/2006 | 01/08/2015 |
Formazione di Todd James
| Moravian College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Investor Relations Contact | 2 |
| Market Strategist | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Finance |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
- Borsa valori
- Insiders
- Todd James
- Esperienza
